血清蛋白谱分析揭示巨细胞动脉炎患者存在不同聚类
研究采用邻近延伸分析检测16例新发巨细胞动脉炎(GCA)和13例已达缓解患者血清中1463种蛋白,无监督聚类识别出三个蛋白特征不同的聚类;聚类1较聚类2多核巨噬细胞移动抑制因子(MIF)升高且NF-κB、STAT5、IL-1信号增强,颅型GCA以内皮和Th17信号改变为特征,前部缺血性视神经病变者CHI3L1(YKL40)和MMP12升高、TIMP3降低。
要点
- 无监督聚类基于蛋白特征将GCA患者分为三个不同聚类。
- 聚类1较聚类2PMR症状更少,MIF升高且NF-κB、STAT5、IL-1信号增强。
- 颅型GCA内皮和Th17信号改变,前部缺血性视神经病变者CHI3L1和MMP12升高、TIMP3降低。
核心结论
- 蛋白谱分析识别出GCA患者具有不同蛋白组学特征的聚类,可能反映不同病理生理机制。
- 这些独特蛋白组学足迹未来可能导向更靶向的治疗。
研究设计与样本
- 采用邻近延伸分析检测新发GCA患者16例和已达缓解患者13例血清样本中的1463种蛋白。
- 进行无监督和有监督聚类分析。
主要发现
- 无监督聚类分析基于蛋白特征识别出三个不同聚类。
- 与聚类2相比,聚类1患者PMR症状更少,巨噬细胞移动抑制因子(MIF)水平升高,NF-κB、STAT5和IL-1信号增强。
- 聚类1和聚类2在缓解时血清蛋白变化不同。
- 颅型GCA患者以内皮和Th17信号改变为特征。
- GUSTO试验中治疗无应答患者表现为Th1信号增强和B细胞信号减弱。
关键数值与推荐
- 新发GCA患者16例,已达缓解患者13例。
- 检测血清蛋白1463种。
- 聚类1较聚类2PMR症状更少,MIF升高且NF-κB、STAT5、IL-1信号增强。
- 前部缺血性视神经病变患者CHI3L1(YKL40)和MMP12升高、TIMP3降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We investigated the potential of serum proteins for distinguishing clinical and molecular subtypes in patients with GCA. METHODS: Proximity extension assays were used to analyse 1463 proteins in serum samples from patients with new-onset GCA (n = 16) and patients who have achieved remission (n = 13). Unsupervised and supervised cluster analyses were performed. RESULTS: Unsupervised cluster analysis identified three distinct clusters based on the protein signature. Compared with cluster 2, patients of cluster 1 had fewer PMR symptoms, increased levels of macrophage migration inhibitory factor (MIF) and pronounced NF-κB, STAT5 and IL-1 signalling. The changes in serum proteins upon remission differed between cluster 1 and 2.Patients with cranial GCA were characterized by altered endothelial and Th17 signalling, whereas patients not responding to treatment within the GUSTO-trial showed increased Th1 and diminished B cell signalling. Patients with anterior ischaemic optic neuropathy displayed higher levels of CHI3L1 (YKL40) and MMP12, and reduced levels of TIMP3. CONCLUSION: Protein profiling identified patient clusters in GCA with distinct proteomic features and therefore likely different pathophysiology. These unique proteomic footprints might lead to more targeted treatments in future.
引用
- Zingg F, Ryser FS, Gloor AD, et al. Serum protein profiling reveals distinct patient clusters in giant cell arteritis. Rheumatology (Oxford). 2024. PMID: 38323660. doi:10.1093/rheumatology/keae072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。